MARTIN KLECKNER III, PhD, MBA, MA - Consultant
work comprises a heavy emphasis on strategic planning, healthcare economics, cost & productivity, and business development for healthcare systems and corporations.
specializes in healthcare economics, strategic planning and execution, quality of care, clinical outcomes, hospital cost & productivity and business alliance management initiatives via six sigma process facilitation, focused studies and analytics; medical technology cost effectiveness & economic impact studies, work flows analyses, process mapping, sales and market development tools, operations management models.
guides healthcare corporations worldwide on the formation of effective business alliances with hospital systems and GPOs.
Major current work comprises capital equipment planning, procurement & logistics for hospital design and development and the formation of healthcare system/university alliances for accelerated BSN and LPN-BSN programs.
Mr. Kleckner is a member of California's Tech Coast Angels concentrating on business development, capitalization and mentoring of life science start-up ventures.
background comprises 27 years guiding emerging and Fortune 100 companies with new technology commercialization throughout Europe, Asia & the Americas.
He is currently serving as investor, advisor and Business Development Officer for RegeneMed, specializing in 3-D engineering of human liver tissue for drug research & discovery and disease therapies.
He is a co-founder of Salvino-Flex LLC, launching a cardio-thoracic device for emergency-trauma applications; and a co-founder with Source Atlantic, specializing in capital equipment planning, high volume procurement and logistics for new hospital construction world-wide.
Earlier medical ventures include diagnostic and therapy approaches for oral, pharyngeal, cervical and ovarian cancers.
Previously he was Founder and CEO of a venture for counter-surveillance technology, receiving worldwide coverage by NBC, CBS, FOX, and the BBC.